Dr. Thomas Ryan Gullatt, MD

Dr. Gullatt practices at Cardiovascular Institute of the South in Baton Rouge, Louisiana.

Dr. Gullatt's NPI, 1750701421, was assigned on April 22, 2014. Dr. Gullatt holds Louisiana license 326260.

Dr. Gullatt's primary practice is Cardiovascular Institute of the South, at 8401 Picardy Ave, Baton Rouge, LA 70809 in East Baton Rouge Parish. The practice phone is (985) 876-0300.

Dr. Gullatt's primary practice is Cardiovascular Institute of the South in Baton Rouge, Louisiana. Dr. Gullatt is also affiliated with Our Lady of the Lake Regional Medical Center. The medical group on file is Cardiovascular Institute of the South. Dmand AI also links Dr. Gullatt to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gullatt practices, 6 sites in all. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Dr. Gullatt's primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Dmand AI has Dr. Gullatt's licenses on file in 2 states: Louisiana and Texas.

CMS data shows 974 Medicare services from Dr. Gullatt across 13 procedure codes in 2024, for 381 Medicare patients. Medicare paid $41,416 for them.

CMS counts 381 Medicare patients who saw Dr. Gullatt in 2024. The largest group is 65 to 74, with 146 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gullatt's median patient age at 61, with 55% women.

In 2024, Dr. Gullatt wrote 803 Medicare Part D claims for 167 patients. 81% of them were for generic drugs. CMS names the drug for 622 of them, across 19 drugs with 11 or more claims each, at $113,357 in total drug cost. In 2023, CMS named 213 claims across 7 drugs.

Dr. Gullatt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of pacemaker insertion or repair by Dr. Gullatt, more than 63% of the clinicians it reports for that procedure.

CMS Open Payments shows 167 general payments to Dr. Gullatt from 19 drug and device companies from 2018 to 2025. Grants make up the largest share, 63% of the total. Abbott Laboratories paid the most, $14,891.